Alcendor Donald J, Juarez Paul D, Matthews-Juarez Patricia, Simon Sheena, Nash Catherine, Lewis Kirollos, Smoot Duane
Center for AIDS Health Disparities Research, Department of Microbiology, Immunology and Physiology, School of Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37208-3599, USA.
Department of Family & Community Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37208-3501, USA.
Vaccines (Basel). 2022 Jan 29;10(2):211. doi: 10.3390/vaccines10020211.
To end or curtail the COVID-19 pandemic, it is essential to incorporate mobile vaccination programs into the national vaccination strategy. Mobile COVID-19 vaccination programs play an important role in providing comprehensive vaccination from federally qualified institutions to underserved communities facing a higher risk for COVID-19 acquisition. The Meharry Medical College COVID-19 mobile vaccine program (MMC-MVP) has provided lifesaving COVID-19 vaccines, free of charge, to communities throughout Middle Tennessee. Mobile deployment is vital for those forced to travel long distances to get vaccinated and who have limited access to medical providers or vaccine clinics, lack access to public transportation, or may be homebound. The MMC-MVP, established on 13 April 2021, via funding from the Bloomberg Foundation, is sourced with infectious disease experts, nurse practitioners, and community engagement personnel to provide COVID-19 vaccinations and information in a culturally competent manner to diverse communities in Middle Tennessee. To provide broader access to COVID-19 vaccinations and vaccine-related information, the MMC-MVP partnered with the Tennessee Community Engagement Alliance, Vanderbilt University School of Nursing COVID-19 vaccine strike teams, non-academic, community-based organizations, and faith-based organizations. During the September 2021 COVID-19 surge in Tennessee, the MMC-MVP provided nearly 5000 free COVID-19 vaccinations to targeted, underserved communities. The MMC-MVP has provided vaccine equity in communities with the highest risk for acquiring COVID-19 and with greatest need in this pandemic.
为了结束或遏制新冠疫情,将移动疫苗接种计划纳入国家疫苗接种战略至关重要。新冠移动疫苗接种计划在从联邦合格机构为面临更高新冠感染风险的服务不足社区提供全面疫苗接种方面发挥着重要作用。梅哈里医学院新冠移动疫苗计划(MMC - MVP)已向田纳西州中部的各个社区免费提供了挽救生命的新冠疫苗。对于那些被迫长途跋涉去接种疫苗、就医或前往疫苗接种诊所机会有限、无法使用公共交通工具或可能居家的人来说,移动接种至关重要。MMC - MVP于2021年4月13日在彭博基金会的资助下成立,配备了传染病专家、执业护士和社区参与人员,以便以文化上适宜的方式向田纳西州中部的不同社区提供新冠疫苗接种和信息。为了让更多人能够接种新冠疫苗并获取与疫苗相关的信息,MMC - MVP与田纳西社区参与联盟、范德比尔特大学护理学院新冠疫苗突击小组、非学术性社区组织以及宗教组织建立了合作关系。在2021年9月田纳西州新冠疫情激增期间,MMC - MVP向目标服务不足社区提供了近5000剂免费新冠疫苗。MMC - MVP在新冠感染风险最高且在此次疫情中需求最大的社区实现了疫苗公平分配。